scispace - formally typeset
E

Evgeniy Yablokov

Researcher at Institute of Business & Medical Careers

Publications -  8
Citations -  76

Evgeniy Yablokov is an academic researcher from Institute of Business & Medical Careers. The author has contributed to research in topics: Prostacyclin & Prostacyclin synthase. The author has an hindex of 3, co-authored 8 publications receiving 35 citations.

Papers
More filters
Journal ArticleDOI

SPR Biosensors in Direct Molecular Fishing: Implications for Protein Interactomics

TL;DR: An original experimental approach based on the use of surface plasmon resonance (SPR) biosensors, applicable for investigation of potential partners involved in protein–protein interactions (PPI) as well as protein–peptide or protein–small molecule interactions.
Journal ArticleDOI

A large-scale comparative analysis of affinity, thermodynamics and functional characteristics of interactions of twelve cytochrome P450 isoforms and their redox partners.

TL;DR: The evolutionary point of view, the type 1 electron transport system (mitCYPs, Adx and NADPH-dependent adrenodoxin reductase (AdR)) increased the specialization of protein-protein interactions (PPI) significantly, which was accompanied by an increase in the specificity of electron transfer.
Journal ArticleDOI

Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context

TL;DR: In this paper, the authors present a systematization and bioinformatic analysis of the available interactomics data on seventeen enzymes in the cholesterol pathway, encoded by HMGCR, MVK, PMVK, MVD, FDPS, FDFT1, SQLE, LSS, DHCR24, CYP51A1, TM7SF2, MSMO1, NSDHL, HSD17B7, EBP, SC5D, DH CR7 genes.
Journal ArticleDOI

Affinity Isolation and Mass Spectrometry Identification of Prostacyclin Synthase (PTGIS) Subinteractome

TL;DR: PTGIS interacted with full-length cytochrome P450 2J2 and glutathione S-transferase (GST), and was shown to bind synthetic peptides corresponding to sequences of for GSTA1, GSTM1, aldo-keto reductase (AKR1A1), glutaredoxin 3 (GLRX3) and histidine triad nucleotide binding protein 2 (HINT2).